The study using the non-small-cell lung cancer cell line, H460 revealed additional information about the relationship between the epidermal growth factor receptor (EGFR) signaling pathway and the expression of NaV1.7 mediated through MAP-kinase ERK1/2 (Campbell et al., 2013). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.